Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 97

1.

Hourly Effect of Pretreatment With IV Antibiotics on Blood Culture Positivity Rate in Emergency Department Patients.

Rand KH, Beal SG, Rivera K, Allen B, Payton T, Lipori GP.

Open Forum Infect Dis. 2019 May 20;6(5):ofz179. doi: 10.1093/ofid/ofz179. eCollection 2019 May.

2.

Dose optimization of moxifloxacin and linezolid against tuberculosis using mathematical modeling and simulation.

Heinrichs MT, Drusano GL, Brown DL, Maynard MS, Sy SKB, Rand KH, Peloquin CA, Louie A, Derendorf H.

Int J Antimicrob Agents. 2019 Mar;53(3):275-283. doi: 10.1016/j.ijantimicag.2018.10.012. Epub 2018 Oct 29.

PMID:
30385322
3.

The "3-Day Rule" for Stool Tests May Not Apply When Using PCR Panels.

Beal SG, Velez L, Tremblay EE, Toffel S, Rand KH.

J Clin Microbiol. 2018 Mar 26;56(4). pii: e02012-17. doi: 10.1128/JCM.02012-17. Print 2018 Apr. No abstract available.

4.

Enhanced in vitro activity of tigecycline in the presence of chelating agents.

Deitchman AN, Singh RSP, Rand KH, Derendorf H.

Int J Antimicrob Agents. 2018 May;51(5):799-802. doi: 10.1016/j.ijantimicag.2017.12.027. Epub 2018 Jan 3.

5.

A Gastrointestinal PCR Panel Improves Clinical Management and Lowers Health Care Costs.

Beal SG, Tremblay EE, Toffel S, Velez L, Rand KH.

J Clin Microbiol. 2017 Dec 26;56(1). pii: e01457-17. doi: 10.1128/JCM.01457-17. Print 2018 Jan.

6.

Relationship between bacteriology report time in the morning and length of stay in hospital after the report.

Rand KH, Beal SG, Lipori GP.

Diagn Microbiol Infect Dis. 2017 Nov;89(3):241-244. doi: 10.1016/j.diagmicrobio.2017.08.005. Epub 2017 Aug 12.

PMID:
28888673
7.

Semi-quantitative Influenza A population averages from a multiplex respiratory viral panel (RVP): potential for reflecting target sequence changes affecting the assay.

Rand KH, Pieretti M, Arcenas R, Beal SG, Houck H, Boslet E, Lednicky JA.

Virol J. 2017 Jul 14;14(1):128. doi: 10.1186/s12985-017-0796-3.

8.

Incidence of central venous catheter hub contamination.

Holroyd JL, Vasilopoulos T, Rice MJ, Rand KH, Fahy BG.

J Crit Care. 2017 Jun;39:162-168. doi: 10.1016/j.jcrc.2017.02.035. Epub 2017 Feb 27.

PMID:
28259730
9.

Hemagglutinin Gene Clade 3C.2a Influenza A(H3N2) Viruses, Alachua County, Florida, USA, 2014-15.

Lednicky JA, Iovine NM, Brew J, Loeb JC, Sugimoto JD, Rand KH, Morris JG Jr.

Emerg Infect Dis. 2016 Jan;22(1):121-3. doi: 10.3201/2201.151019.

10.

Sample-to-result molecular infectious disease assays: clinical implications, limitations and potential.

Beal SG, Assarzadegan N, Rand KH.

Expert Rev Mol Diagn. 2016;16(3):323-41. doi: 10.1586/14737159.2016.1134325. Epub 2016 Jan 11. Review.

PMID:
26689497
11.

Clinical and economic impact of antimicrobial stewardship interventions with the FilmArray blood culture identification panel.

Pardo J, Klinker KP, Borgert SJ, Butler BM, Giglio PG, Rand KH.

Diagn Microbiol Infect Dis. 2016 Feb;84(2):159-64. doi: 10.1016/j.diagmicrobio.2015.10.023. Epub 2015 Nov 11.

PMID:
26639226
12.

A rare case of classical Hodgkin's lymphoma in the setting of a newly diagnosed left atrial myxoma.

Bolanos AJ, Dibu G, Burke FW, Klodell CT, Li Y, Rand KH, Lucas AR.

BMJ Case Rep. 2015 Oct 29;2015. pii: bcr2015212466. doi: 10.1136/bcr-2015-212466.

13.

Multiplex gastrointestinal pathogen panels: implications for infection control.

Rand KH, Tremblay EE, Hoidal M, Fisher LB, Grau KR, Karst SM.

Diagn Microbiol Infect Dis. 2015 Jun;82(2):154-7. doi: 10.1016/j.diagmicrobio.2015.01.007. Epub 2015 Jan 22.

PMID:
25796558
14.

Direct identification of bacteria in positive blood cultures: comparison of two rapid methods, FilmArray and mass spectrometry.

Rand KH, Delano JP.

Diagn Microbiol Infect Dis. 2014 Jul;79(3):293-7. doi: 10.1016/j.diagmicrobio.2014.03.014. Epub 2014 Mar 22.

PMID:
24767683
15.

Detection of Neisseria meningitidis from negative blood cultures and cerebrospinal fluid with the FilmArray blood culture identification panel.

Pardo J, Klinker KP, Borgert SJ, Butler BM, Rand KH, Iovine NM.

J Clin Microbiol. 2014 Jun;52(6):2262-4. doi: 10.1128/JCM.00352-14. Epub 2014 Apr 16.

16.

Universal intravenous access cleaning device fails to sterilize stopcocks.

Holroyd JL, Paulus DA, Rand KH, Enneking FK, Morey TE, Rice MJ.

Anesth Analg. 2014 Feb;118(2):333-43. doi: 10.1213/ANE.0000000000000059.

PMID:
24445634
17.

Time to positivity of blood cultures supports antibiotic de-escalation at 48 hours.

Pardo J, Klinker KP, Borgert SJ, Trikha G, Rand KH, Ramphal R.

Ann Pharmacother. 2014 Jan;48(1):33-40. doi: 10.1177/1060028013511229. Epub 2013 Nov 18.

PMID:
24259644
18.

Intestinal dysbiosis and depletion of butyrogenic bacteria in Clostridium difficile infection and nosocomial diarrhea.

Antharam VC, Li EC, Ishmael A, Sharma A, Mai V, Rand KH, Wang GP.

J Clin Microbiol. 2013 Sep;51(9):2884-92. doi: 10.1128/JCM.00845-13. Epub 2013 Jun 26.

19.

Comparison of two multiplex methods for detection of respiratory viruses: FilmArray RP and xTAG RVP.

Rand KH, Rampersaud H, Houck HJ.

J Clin Microbiol. 2011 Jul;49(7):2449-53. doi: 10.1128/JCM.02582-10. Epub 2011 Apr 20.

20.

Clinical laboratory detection of AmpC β-lactamase: does it affect patient outcome?

Rand KH, Turner B, Seifert H, Hansen C, Johnson JA, Zimmer A.

Am J Clin Pathol. 2011 Apr;135(4):572-6. doi: 10.1309/AJCP7VD0NMAMQCWA.

PMID:
21411779
21.

Ultrastructural, immunofluorescence, and RNA evidence support the hypothesis of a "new" virus associated with Kawasaki disease.

Rowley AH, Baker SC, Shulman ST, Rand KH, Tretiakova MS, Perlman EJ, Garcia FL, Tajuddin NF, Fox LM, Huang JH, Ralphe JC, Takahashi K, Flatow J, Lin S, Kalelkar MB, Soriano B, Orenstein JM.

J Infect Dis. 2011 Apr 1;203(7):1021-30. doi: 10.1093/infdis/jiq136.

22.

Clinical pharmacokinetics and pharmacodynamics of tigecycline.

Barbour A, Schmidt S, Ma B, Schiefelbein L, Rand KH, Burkhardt O, Derendorf H.

Clin Pharmacokinet. 2009;48(9):575-84. doi: 10.2165/11317100-000000000-00000. Review.

PMID:
19725592
23.

Ceftobiprole: a novel cephalosporin with activity against Gram-positive and Gram-negative pathogens, including methicillin-resistant Staphylococcus aureus (MRSA).

Barbour A, Schmidt S, Rand KH, Derendorf H.

Int J Antimicrob Agents. 2009 Jul;34(1):1-7. doi: 10.1016/j.ijantimicag.2008.12.012. Epub 2009 Mar 3. Review.

PMID:
19261449
24.

Evaluation of repeat Clostridium difficile enzyme immunoassay testing.

Cardona DM, Rand KH.

J Clin Microbiol. 2008 Nov;46(11):3686-9. doi: 10.1128/JCM.00931-08. Epub 2008 Sep 24.

25.

PK/PD: new insights for antibacterial and antiviral applications.

Schmidt S, Barbour A, Sahre M, Rand KH, Derendorf H.

Curr Opin Pharmacol. 2008 Oct;8(5):549-56. doi: 10.1016/j.coph.2008.06.010. Epub 2008 Jul 30. Review.

PMID:
18625339
26.

Clinical microdialysis in skin and soft tissues: an update.

Schmidt S, Banks R, Kumar V, Rand KH, Derendorf H.

J Clin Pharmacol. 2008 Mar;48(3):351-64. doi: 10.1177/0091270007312152. Review.

PMID:
18285620
27.

Use of bronchoalveolar lavage to detect galactomannan for diagnosis of pulmonary aspergillosis among nonimmunocompromised hosts.

Nguyen MH, Jaber R, Leather HL, Wingard JR, Staley B, Wheat LJ, Cline CL, Baz M, Rand KH, Clancy CJ.

J Clin Microbiol. 2007 Sep;45(9):2787-92. Epub 2007 Jun 27.

28.

Bronchoalveolar lavage galactomannan in diagnosis of invasive pulmonary aspergillosis among solid-organ transplant recipients.

Clancy CJ, Jaber RA, Leather HL, Wingard JR, Staley B, Wheat LJ, Cline CL, Rand KH, Schain D, Baz M, Nguyen MH.

J Clin Microbiol. 2007 Jun;45(6):1759-65. Epub 2007 Apr 11.

29.

The AmpC inhibitor, Syn2190, can be used to reveal extended-spectrum beta-lactamases in Escherichia coli.

Netzel TC, Jindani I, Hanson N, Turner BM, Smith L, Rand KH.

Diagn Microbiol Infect Dis. 2007 Jul;58(3):345-8. Epub 2007 Mar 26.

PMID:
17379469
30.

Daptomycin-reversible rifampicin resistance in vancomycin-resistant Enterococcus faecium.

Rand KH, Houck HJ, Silverman JA.

J Antimicrob Chemother. 2007 May;59(5):1017-20. Epub 2007 Mar 16.

PMID:
17369277
31.

Pharmacokinetic/pharmacodynamic modeling of in vitro activity of azithromycin against four different bacterial strains.

Treyaprasert W, Schmidt S, Rand KH, Suvanakoot U, Derendorf H.

Int J Antimicrob Agents. 2007 Mar;29(3):263-70. Epub 2006 Dec 27.

PMID:
17194570
32.

Errors in interpretation of Gram stains from positive blood cultures.

Rand KH, Tillan M.

Am J Clin Pathol. 2006 Nov;126(5):686-90.

PMID:
17050065
33.

Pharmacokinetic-pharmacodynamic modelling of antibacterial activity of cefpodoxime and cefixime in in vitro kinetic models.

Liu P, Rand KH, Obermann B, Derendorf H.

Int J Antimicrob Agents. 2005 Feb;25(2):120-9.

PMID:
15664481
34.
35.

PK-PD modelling of the effect of cefaclor on four different bacterial strains.

de la Peña A, Gräbe A, Rand KH, Rehak E, Gross J, Thyroff-Friesinger U, Müller M, Derendorf H.

Int J Antimicrob Agents. 2004 Mar;23(3):218-25.

PMID:
15164961
36.

Daptomycin synergy with rifampicin and ampicillin against vancomycin-resistant enterococci.

Rand KH, Houck H.

J Antimicrob Chemother. 2004 Mar;53(3):530-2. Epub 2004 Feb 12.

PMID:
14963062
38.

Epstein-Barr virus nuclear antigen-1 (EBNA-1) associated oligoclonal bands in patients with multiple sclerosis.

Rand KH, Houck H, Denslow ND, Heilman KM.

J Neurol Sci. 2000 Feb 1;173(1):32-9.

PMID:
10675577
39.
40.
41.

Molecular approach to find target(s) for oligoclonal bands in multiple sclerosis.

Rand KH, Houck H, Denslow ND, Heilman KM.

J Neurol Neurosurg Psychiatry. 1998 Jul;65(1):48-55.

42.

Rejection criteria for endotracheal aspirates in neonates. Clinical impact.

Rand KH.

Diagn Microbiol Infect Dis. 1997 Mar;27(3):55-61.

PMID:
9147005
43.

Determination of free extracellular concentrations of piperacillin by microdialysis.

Nolting A, Costa TD, Vistelle R, Rand KH, Derendorf H.

J Pharm Sci. 1996 Apr;85(4):369-72.

PMID:
8901070
44.

Pharmacokinetic-pharmacodynamic modeling of the antibiotic effect of piperacillin in vitro.

Nolting A, Dalla Costa T, Rand KH, Derendorf H.

Pharm Res. 1996 Jan;13(1):91-6.

PMID:
8668686
46.

Detection of candidemia by polymerase chain reaction.

Rand KH, Houck H, Wolff M.

Mol Cell Probes. 1994 Jun;8(3):215-21.

PMID:
7969195
47.

Relationship of the polymerase chain reaction for cytomegalovirus to the development of hepatitis in liver transplant recipients.

Wolff MA, Rand KH, Houck HJ, Brunson ME, Howard RJ, Langham MR, Davis GL, Mailliard ME, Myers BM, Andres J, et al.

Transplantation. 1993 Sep;56(3):572-6.

PMID:
8212151
48.

Reproducibility of the microdilution checkerboard method for antibiotic synergy.

Rand KH, Houck HJ, Brown P, Bennett D.

Antimicrob Agents Chemother. 1993 Mar;37(3):613-5.

49.

Vancomycin is not an essential component of the initial empiric treatment regimen for febrile neutropenic patients receiving ceftazidime: a randomized prospective study.

Ramphal R, Bolger M, Oblon DJ, Sherertz RJ, Malone JD, Rand KH, Gilliom M, Shands JW Jr, Kramer BS.

Antimicrob Agents Chemother. 1992 May;36(5):1062-7.

50.

Quantitative tip culture methods and the diagnosis of central venous catheter-related infections.

Raad II, Sabbagh MF, Rand KH, Sherertz RJ.

Diagn Microbiol Infect Dis. 1992 Jan;15(1):13-20. Erratum in: Diagn Microbiol Infect Dis 1992 May-Jun;15(4):384.

PMID:
1730183

Supplemental Content

Support Center